Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


GPhC tells 10 online pharmacies to stop supply of codeine linctus

The GPhC told 10 online pharmacies they must not sell or supply codeine linctus after intelligence-led inspections identified “serious risks to patient safety”.

Of the 38 pharmacies the General Pharmaceutical Council (GPhC) placed conditions on between April 1 last year and January 31, 12 are online pharmacies, with the majority chastised for “the online, over-the-counter supply of codeine linctus and promethazine-containing medicines”, a spokesperson told C+D last week (February 17).

C+D previously reported that there was an increase in enforcement notices placed on pharmacies between October-December 2020, due to the “high purchase numbers of codeine linctus”.

Two of the online pharmacies that were identified in the nine-month period have since ceased trading, following the intelligence-led inspections.

On March 17 last year, the GPhC announced it would stop all routine inspections with immediate effect. However, intelligence-led inspections continued during the pandemic.

The twelve online pharmacies that had conditions placed on their practice are:

  • Letterbox Meds Ltd (ceased trading)
  • Innox Trading Ltd, trading as Chemist4u (GPhC registration number:1103628)
  • MyDrugs Ltd (ceased trading)
  • Simple Online Healthcare Ltd, trading as Simple Online Pharmacy (9011287)
  • AYP Healthcare in Preston (9011187)
  • AYP Healthcare in Romford (9010499)
  • Health Pharm (Leicester) Ltd, trading as Howitts Pharmacy (1110111)
  • Dr Rani Ltd, trading as Evercaring pharmacy (1116378)
  • Online Express Medicines Ltd, trading as Simply Meds Online (9010764)
  • Online Express Medicines Ltd, trading as Simply Meds Online (9010240)
  • Vishyus Pharma Ltd, trading as (9011206)
  • Smartcare Pharmacy (9010056)


C+D has approached the 10 online pharmacies that are still in business for comments.


Notices: ban on codeine linctus and promethazine sales

The 10 online pharmacies approached by C+D had all been instructed by the GPhC “not sell or supply any codeine linctus preparations”, until certain conditions are met, “with the exception of supplying these medicines against an NHS prescription”, the GPhC enforcement notices state.

The pharmacies were also told not to “sell or supply any medicines containing promethazine as an active ingredient”, although some can supply these medicines through an NHS prescription.

The enforcement notice served to Smartcare Pharmacy (9010056) specifies that the pharmacy must also not “obtain” preparations containing codeine linctus nor “obtain, sell or supply any preparation containing promethazine as a single active ingredient”. (9011206) was also forbidden from selling or supplying “any medicines containing cyclizine”. The pharmacy told C+D last week (February 16) that it preferred not to comment.

AYP Healthcare’s Romford site, which was served an enforcement notice on October 22 last year, was later inspected on December 10 and achieved a “standards all met” result. When approached by C+D, the pharmacy – which also owns a site in Preston, Lancashire – said it preferred not to comment.

The regulator placed conditions on 20 pharmacies between April 2019 and March 2020, 17 of which were online pharmacies, C+D reported last year (August 8).

In the nine months to January 2021, the regulator placed conditions on 38 pharmacies – both online and bricks-and-mortar – while it served improvement notices to four other pharmacies, according to the GPhC spokesperson.

Do you think codeine linctus should be reclassified to POM?

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts